Union Square Park Partners, LP 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:01 am Purchase |
2024-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Union Square Park Partners, LP | 1,485,677 11.440% |
164,292 (+12.43%) |
Filing |
| 2024-10-31 1:36 pm Purchase |
2024-10-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Union Square Park Partners, LP | 1,321,385 10.170% |
129,895 (+10.90%) |
Filing |
| 2024-10-08 12:42 pm Purchase |
2024-10-03 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Union Square Park Partners, LP | 1,191,490 9.170% |
1,191,490 (New Position) |
Filing |